[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]

Rev Pneumol Clin. 1991;47(4):188-91.
[Article in French]

Abstract

A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology. Conversely, patients with visceral leishmaniasis must be investigated for a cause of immunosuppression with, in particular, biopsy of accessible lymph nodes. The exceptionally favourable course of this particular case deserved to be high-lighted.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols*
  • Antiprotozoal Agents / therapeutic use
  • Bleomycin / administration & dosage
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Hodgkin Disease / complications*
  • Hodgkin Disease / drug therapy
  • Humans
  • Immunocompromised Host*
  • Leishmaniasis, Visceral / complications*
  • Leishmaniasis, Visceral / drug therapy
  • Mechlorethamine / administration & dosage
  • Meglumine / therapeutic use
  • Meglumine Antimoniate
  • Opportunistic Infections / complications*
  • Organometallic Compounds / therapeutic use
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Vinblastine
  • Vincristine / administration & dosage

Substances

  • Antiprotozoal Agents
  • Organometallic Compounds
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Meglumine
  • Meglumine Antimoniate
  • Dacarbazine
  • Doxorubicin
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • MOPP protocol